National Development and Reform Commission plans to adjust the price of Chinese patent medicine

According to Yubo intelligence industry market research center, the national development and Reform Commission is preparing a plan to adjust the price of Chinese patent medicine, which is expected to be released early next year The object of price adjustment is the Chinese patent medicine of non-state essential drugs within the government pricing range It is reported that the national development and Reform Commission follows four principles in adjusting the price of Chinese patent medicine: first, it should be basically consistent with the price policy of chemical medicine, and fully reflect the characteristics of Chinese patent medicine The second is to fully consider the rising trend of Chinese herbal medicine prices, the production costs of Chinese patent medicine leading enterprises, market transaction prices and other factors Third, we will not reduce the price of low-cost drugs, appropriately raise the price of the drugs that are hung upside down due to the rising cost, appropriately reduce the decline of innovative drugs, and increase the price reduction of high-cost drugs Fourth, in principle, the adjusted maximum retail price shall not be higher than the actual average bid winning retail price, except for the varieties whose prices are increased Relevant research report of Chinese patent medicine 2014-2018 prediction and analysis report of investment prospect of global Chinese patent medicine industry domestic market research and development panoramic prediction report of Chinese patent medicine industry feasibility study report of Chinese patent medicine and granule production line and R & D center project 2012-2017 market sales analysis and development prospect prediction report of Chinese liver disease Chinese patent medicine industry 2012-2017 China orthopedic Zhongcheng Analysis report on development status and investment prospect of pharmaceutical industry more analysis on pharmaceutical industry About the specific price adjustment details, according to the sources, there are low-cost drugs for the secret prescription drugs of national secret level and above, which do not seem to reduce the price at present; in addition to the national secret varieties, the high-quality and high-price Chinese patent drugs need to be adjusted by 10% reduction, and the adjusted reduction is more than 25%, which can be put in place in two years, which means that many exclusive traditional Chinese medicine varieties will be reduced; and The first is to increase the maximum retail price of Chinese patent medicines whose raw materials (market area) have increased more, which will be allowed to increase on the basis of cost, but these Chinese patent medicines must be clinically necessary or first-aid medicines specified in the Pharmacopoeia To master the latest report step by step, please refer to the Research Report on prediction and analysis of investment prospect of global Chinese patent medicine industry in 2014-2018.